Severe neutrophilia induced by infliximab for psoriasis [19]

British Journal of Dermatology

Volumn 158, Issue 1, 2008, Pages 200-201

  De Oliveira, J P ^a   Levy, A ^a   Morel, P ^a   Guibal, F ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Infliximab; Neutrophilia; Psoriasis; Side effects

Indexed keywords

ANTIHISTAMINIC AGENT; DEXCHLORPHENIRAMINE; DNA; ETRETIN; HYDROCORTISONE SODIUM SUCCINATE; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; STEROID;

ADULT; ANAMNESIS; ARTHRALGIA; CASE REPORT; CHEST TIGHTNESS; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPNEA; EMERGENCY WARD; FLUSHING; HUMAN; LABORATORY TEST; LETTER; MALE; NEUTROPHILIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; SIDE EFFECT; SORE THROAT; TACHYCARDIA; ULTRAVIOLET A RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; LEUKOCYTOSIS; MALE; NEUTROPHILS; PSORIASIS;

EID: 36849053333     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08319.x     Document Type: Letter

References (7)

1. Thielen AM, Kuenzli S, Saurat JH. Cutaneous adverse events of biological therapy for psoriasis: review of the literature. Dermatology 2005 211 : 209 17.
2. De Bandt M, Sibilia J, Le Loet X et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005 7 : R545 51.
3. Krishnan RS, Hsu S. Serum sickness due to infliximab in a patient with psoriasis. J Drugs Dermatol 2004 3 : 305 8.
4. Favalli EG, Varenna M, Sinigaglia L. Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clin Exp Rheumatol 2005 23 : 247 50.
5. Vidal F, Fontova R, Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 2003 139 : W63 (Letter).
6. Pay S, Musaback U, Erdem H et al. Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils. Immunopharmacol Immunotoxicol 2005 27 : 187 98.
7. Rubin RL. Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs. Clin Biochem 1995 25 : 223 34.